CAPTRUST Financial Advisors’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,349
Closed -$77K 4617
2022
Q2
$77K Buy
2,349
+526
+29% +$16.6K ﹤0.01% 2423
2022
Q1
$48K Buy
1,823
+1,058
+138% +$25.8K ﹤0.01% 2811
2021
Q4
$18K Sell
765
-60
-7% -$1.48K ﹤0.01% 3386
2021
Q3
$21K Buy
825
+92
+13% +$2.34K ﹤0.01% 3145
2021
Q2
$19K Sell
733
-5
-0.7% -$136 ﹤0.01% 3156
2021
Q1
$19K Buy
738
+673
+1,035% +$17.3K ﹤0.01% 3053
2020
Q4
$1K Buy
+65
New +$1.27K ﹤0.01% 3346
2019
Q2
Sell
-52
Closed -$1K 2038
2019
Q1
$1K Buy
+52
New +$1.55K ﹤0.01% 1778
2018
Q2
Sell
-28
Closed -$1K 1633
2018
Q1
$1K Buy
+28
New +$886 ﹤0.01% 1305

Other funds holding NTUS

CAPTRUST Financial Advisors's NTUS Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 2,349 shares — an estimated $77K sold.

CAPTRUST Financial Advisors first reported a position in NTUS in Q1 2018 and held it in 9 quarters. The position peaked at $77K in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,349 Natus Medical Inc shares in Q3 2022, an estimated $77K.
  • CAPTRUST Financial Advisors first reported a position in Natus Medical Inc in Q1 2018 and held it in 9 quarters.
  • CAPTRUST Financial Advisors's Natus Medical Inc position peaked at $77K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.